Sitagliptin
Sitagliptin Bioton contains the active substance sitagliptin, which belongs to a class of medications called DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors), which reduce blood sugar levels in adults with type 2 diabetes.
This medication helps to increase the amount of insulin released after a meal and decrease the amount of sugar produced by the body.
Your doctor has prescribed this medication to reduce high blood sugar levels caused by type 2 diabetes. It can be used alone or in combination with other medications (insulin, metformin, sulfonylureas, or glitazones) that lower blood sugar levels, which may already be taken with meals and a physical exercise program.
What is type 2 diabetes?
Type 2 diabetes is a condition where the body does not produce enough insulin, and the insulin produced does not work as it should. The body may also produce too much sugar. If this happens, sugar (glucose) builds up in the blood. This can lead to serious health problems, such as heart disease, kidney disease, loss of vision, and limb amputation.
Patients taking Sitagliptin Bioton have reported cases of pancreatitis (see section 4).
If you develop blisters on your skin, it may be a sign of a condition called bullous pemphigoid. Your doctor may advise you to stop taking sitagliptin.
Please inform your doctor if you have or have had:
Since this medication does not work when blood sugar levels are low, it is unlikely to cause low blood sugar levels. However, if this medication is taken with a sulfonylurea or insulin, it may cause low blood sugar levels (hypoglycemia). Your doctor may reduce the dose of the sulfonylurea or insulin.
Children and adolescents under 18 years of age should not take this medication. It is not known if this medication is safe and effective in children and adolescents under 18 years of age.
Tell your doctor or pharmacist about all medications you are taking, have recently taken, or might take.
In particular, inform your doctor if you are taking digoxin (a medication used to treat heart rhythm disorders and other heart conditions). When taking Sitagliptin Bioton with digoxin, your doctor may need to monitor your digoxin blood levels.
This medication can be taken with or without food and drink.
If you are pregnant, breastfeeding, think you may be pregnant, or plan to have a baby, ask your doctor or pharmacist for advice before taking this medication.
Do not take this medication during pregnancy.
It is not known if this medication passes into breast milk. Do not take this medication while breastfeeding or if breastfeeding is planned.
This medication has no or negligible influence on the ability to drive and use machines. However, when driving or using machines, consider that dizziness and drowsiness have been reported.
Taking this medication with sulfonylureas or insulin may cause low blood sugar levels (hypoglycemia), which can affect the ability to drive and use machines or work without safe foot support.
This medication contains less than 1 mmol (23 mg) of sodium per dose, which means it is essentially "sodium-free".
Always take this medication exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
The recommended dose is:
If you have kidney problems, your doctor may prescribe a lower dose of this medication (e.g., 25 mg or 50 mg).
Your doctor may prescribe this medication alone or with other medications that lower blood sugar levels.
Diet and exercise help your body use the sugar in your blood. While taking Sitagliptin Bioton, it is important to follow the diet and exercise plan recommended by your doctor.
If you take more than the recommended dose of this medication, contact your doctor immediately.
If you miss a dose, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule.
Do not take a double dose.
To maintain control of your blood sugar levels, you should continue to take this medication for as long as your doctor recommends. Do not stop taking this medication without consulting your doctor first.
If you have any further questions on the use of this medication, ask your doctor or pharmacist.
Like all medications, Sitagliptin Bioton can cause side effects, although not everybody gets them.
STOP taking Sitagliptin Bioton and contact your doctor immediately if you experience any of the following serious side effects:
If you experience a severe allergic reaction (frequency not known), including rash, hives, blisters on the skin, or peeling of the skin, and swelling of the face, lips, tongue, and throat, which may cause difficulty breathing or swallowing, stop taking this medication and contact your doctor immediately. Your doctor may prescribe a medication to treat the allergic reaction and another medication to treat your diabetes.
In some patients who added sitagliptin to metformin, the following side effects were reported:
Common (may affect up to 1 in 10 people): low blood sugar levels, nausea, bloating, vomiting.
Uncommon (may affect up to 1 in 100 people): stomach pain, diarrhea, constipation, drowsiness.
Some patients experienced various gastrointestinal symptoms after starting treatment with sitagliptin in combination with metformin (common).
In some patients who took sitagliptin in combination with a sulfonylurea and metformin, the following side effects were reported:
Very common (may affect more than 1 in 10 people): low blood sugar levels
Common: constipation
In some patients who took sitagliptin and pioglitazone, the following side effects were reported:
Common: bloating, swelling of the hands or feet
In some patients who took sitagliptin in combination with pioglitazone and metformin, the following side effects were reported:
Common: swelling of the hands or feet
In some patients who took sitagliptin in combination with insulin (with or without metformin), the following side effects were reported:
Common: flu
Uncommon: dry mouth
In some patients who took sitagliptin alone or with other anti-diabetic medications in clinical trials or after marketing authorization, the following side effects were reported:
Common: low blood sugar levels, headache, upper respiratory tract infections, stuffy or runny nose and sore throat, osteoarthritis, pain in the arm or leg
Uncommon: dizziness, constipation, itching
Rare: reduced platelet count
Frequency not known: kidney disease (sometimes requiring dialysis), vomiting, joint pain, muscle pain, back pain, interstitial lung disease, bullous pemphigoid (a type of blistering skin condition)
If you experience any side effects, including those not listed in this leaflet, please inform your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Medicinal Product Monitoring, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products: Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: 22 49-21-301, fax: 22 49-21-309, website: https://smz.ezdrowie.gov.pl .
Side effects can also be reported to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiry date stated on the blister and carton after "EXP".
The expiry date refers to the last day of the month.
There are no special storage instructions for this medication.
Medications should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medications that are no longer needed. This will help protect the environment.
Round, beige film-coated tablets.
Non-transparent PVC/PE/PVDC/Aluminum blister pack. Packs of 28 film-coated tablets.
BIOTON S.A.
ul. Starościńska 5
02-516 Warsaw
Poland
SAG Manufacturing, S.L.U.
Ctra. N-I, Km 36
28750 San Agustín de Guadalix, Madrid
Spain
Galenicum Health, S.L.U.
Sant Gabriel, 50.
08950 Esplugues de Llobregat, Barcelona
Spain
For more information on this medication, please contact:
BIOTON S.A.
02-516 Warsaw
ul. Starościńska 5
Tel: + 48 (22) 721 40 00
bioinfo@bioton.com
Malta: Sitagliptin Adair 100 mg film-coated tablets
Poland: SITAGLIPTIN BIOTON
France: SITAGLIPTINE BGR 100 mg, film-coated tablet
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.